Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response
Author:
Funder
Cancer Prevention and Research Institute of Texas
National Institutes of Health
Publisher
Elsevier BV
Subject
Molecular Biology,Biophysics
Reference143 articles.
1. Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy;Abbotts;Oncotarget,2014
2. Design and synthesis of 3-carbamoylbenzoic acid derivatives as inhibitors of human apurinic/apyrimidinic endonuclease 1 (APE1);Aiello;ChemMedChem,2012
3. Poly(ADP-Ribosyl)ation by PARP1: reaction mechanism and regulatory proteins;Alemasova;Nucleic Acids Res.,2019
4. Recognition and repair of chemically heterogeneous structures at DNA ends;Andres;Environ. Mol. Mutagen.,2015
5. Fragment screening using capillary electrophoresis (CEfrag) for hit identification of heat shock protein 90 ATPase inhibitors;Austin;J. Biomol. Screen,2012
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Genome-wide pan-GPCR cell libraries accelerate drug discovery;Acta Pharmaceutica Sinica B;2024-06
2. Comprehensive Whole Genome Sequencing Reveals Origins of Mutational Signatures Associated with Aging and Temozolomide Chemotherapy;2024-04-20
3. AP endonuclease 1: Biological updates and advances in activity analysis;Methods in Enzymology;2024
4. A New Drug Discovery Platform: Application to DNA Polymerase Eta and Apurinic/Apyrimidinic Endonuclease 1;International Journal of Molecular Sciences;2023-11-23
5. Molecular Docking on SARSCOV2 Target Protein;2023 2nd International Conference on Ambient Intelligence in Health Care (ICAIHC);2023-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3